Celsius (NASDAQ:CELH – Free Report) had its price target cut by UBS Group from $45.00 to $39.00 in a research note issued to investors on Thursday morning,Benzinga reports. They currently have a buy rating on the stock.
CELH has been the subject of a number of other reports. Jefferies Financial Group reduced their price target on shares of Celsius from $44.00 to $40.00 and set a “buy” rating for the company in a research report on Thursday, December 19th. B. Riley cut their target price on shares of Celsius from $50.00 to $47.00 and set a “buy” rating for the company in a research report on Monday, November 4th. Deutsche Bank Aktiengesellschaft started coverage on shares of Celsius in a report on Thursday, December 12th. They set a “hold” rating and a $32.00 price target on the stock. Roth Mkm cut their price objective on Celsius from $40.00 to $38.00 and set a “buy” rating for the company in a report on Monday, December 16th. Finally, JPMorgan Chase & Co. initiated coverage on Celsius in a research report on Thursday, December 12th. They set an “overweight” rating and a $37.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $49.94.
Read Our Latest Report on CELH
Celsius Trading Up 1.1 %
Insider Activity at Celsius
In other Celsius news, major shareholder William H. Milmoe sold 65,000 shares of the company’s stock in a transaction dated Thursday, December 12th. The shares were sold at an average price of $31.15, for a total transaction of $2,024,750.00. Following the completion of the sale, the insider now directly owns 261,245 shares in the company, valued at $8,137,781.75. This represents a 19.92 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 2.20% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On Celsius
Large investors have recently made changes to their positions in the business. Worldquant Millennium Advisors LLC increased its position in Celsius by 993.0% in the 3rd quarter. Worldquant Millennium Advisors LLC now owns 1,180,904 shares of the company’s stock worth $37,033,000 after buying an additional 1,072,859 shares during the period. MIG Capital LLC acquired a new stake in shares of Celsius in the third quarter worth $30,358,000. Dimensional Fund Advisors LP increased its position in Celsius by 86.9% during the second quarter. Dimensional Fund Advisors LP now owns 990,135 shares of the company’s stock worth $56,531,000 after acquiring an additional 460,227 shares during the period. Lighthouse Investment Partners LLC acquired a new position in Celsius during the 2nd quarter valued at $20,024,000. Finally, Charles Schwab Investment Management Inc. grew its position in Celsius by 19.1% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,381,279 shares of the company’s stock worth $43,317,000 after purchasing an additional 221,833 shares during the last quarter. Institutional investors and hedge funds own 60.95% of the company’s stock.
About Celsius
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
Featured Stories
- Five stocks we like better than Celsius
- Using the MarketBeat Dividend Tax Calculator
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- 3 Healthcare Dividend Stocks to Buy
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- Stock Average Calculator
- Micron Technology: Riding the AI Wave to Long-Term Growth
Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.